Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2021

Jul 8, 2021

32485_dirs_2021-07-07_e5869749-01af-45e8-97ec-fad29f1b2780.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Social Capital Suvretta Holdings Corp. III (DNAC)
CIK: 0001850270
Period of Report: 2021-07-02

Reporting Person: SCS Sponsor III LLC (Director, 10% Owner)
Reporting Person: Palihapitiya Chamath (Director, Chief Executive Officer, 10% Owner)
Reporting Person: Mehta Kishan (Director, President, 10% Owner)
Reporting Person: Cowen Aaron (10% Owner)
Reporting Person: ChaChaCha DNA III, LLC (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-07-02 Class A ordinary shares A 640000 $10.00 Acquired 640000 Direct

Footnotes

F1: The reporting owner, SCS Sponsor III LLC (the "Sponsor"), in whose name the securities reported herein are held, is managed by its managers,
Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA III, LLC ("ChaChaCha"),
which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein.